Sodium,Micafungin,Pneumocandins

Pneumocandins

 

 

Micafungin Sodium,208538-73-2
Micafungin Sodium
Micafungin Sodium
Name
Micafungin Sodium
Molecular Formula
C56H71N9O23S.Na
Molecular Weight
1292.28
CAS
208538-73-2
Systematic Name
FK 463
Price
US$990/100mg
Certificate of analysis
Micafungin Sodium,208538-73-2
View via PDF file
Micafungin Sodium
Specification
Appearance
White to off-white powder
Complies
Solubility
Freely soluble in DMSO and methanol
Conforms
Identification
A:The HPLC RT should correspond to that of reference standard.
B:IR And UV correspond to the related rule
Conforms
Water
1.6%-3.0%
1.8%
Single impurities
≤3.0%
1.7%
Total impurities
≤5.0%
1.2%
Heavy metals
≤20mg/L
Conforms
Assay(by HPLC)
Micafungin >90%
98.26%
Storage
Should be stored at a temperature below -20℃
Contact us for more information
Chemical information
Compound Name*
CAS No. "N/A" if the CAS not available*
Quantity*
Contact information
Contact person*
Email Address *
Tel No.*
Company or Organization Name*
Shipping Address*
Country
Remarks

<Privacy policy: the contact information will be only used for this business contact>

Related Pneumocandins
Patent Disclaimer
PD1
Products protected by valid patents are not offered for sale in jurisdictions where the sale of such products constitutes a patent infringement. The current list only reflects the products and technologies that are available, under development: note that some products may be developed or produced for internal and experimental uses with no commercal aim.
PD2
Sales of products are limited to those allowed by Chapter VII PLPRC 63, the above includes Research and development quantities.
PD3
the buyer assumes responsibility of all patent considerations in the use of Micafungin Sodium,208538-73-2 fromLano ’s Pharmaceutical Co.,Ltd.
PD4
R&D use in accordance with (1) 35 USC 271(e)+A13(1) in the U.S.; (2) Section 69.1 of Japanese Patent Law in Japan; (3) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (4) Sections 55.2(1) and 55.2(6) and other common law exemptions of Canadian patent law; (5) Section 68B of the Patents Act of 1953 in New Zealand together with the amendment of same by the Statutes Amendment Bill of 2002; (6) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (7) such similar laws and rules as may apply in various other countries.